ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Anal Bioanal Tech, Vol 12(6)
  • DOI: 10.4172/2155-9872.1000432

Crystal Structures of New Ivermectin Pseudopolymorphs

Shubin K, Bērziņš A and Belyakov S*
Department of Applied Chemistry, Latvian Institute of Organic Synthesis, Riga, Latvia
*Corresponding Author: Belyakov S, Research Department, J-Star Research Inc, US, Email: kaushalendra.chaturvedi@my.liu.edu

Received: 01-Jun-2021 / Accepted Date: 15-Jun-2021 / Published Date: 22-Jun-2021 DOI: 10.4172/2155-9872.1000432

Abstract

Ivermectin is a macrocyclic lactone developed in the 1980’s as a multitarget drug. In the present study it was performed an analysis of crystal structure of new pseudopolymorphs of ivermectin using X-ray diffraction and quantum chemical methods.

Keywords:    Ivermectin; Pseudopolymorph; Crystal structure analysis

Commentary

New pseudopolymorphs of ivermectin (IVM), a potential anti‐ COVID‐19 drug [1,2], were prepared [3]. The crystal structure for three pseudopolymorphic crystalline forms of IVM has been determined using single‐crystal X‐ray crystallographic analysis. It is well known that the semisynthetic substance of IVM represents a mixture of two macrocyclic compounds ivermectin-B1a and ivermectin-B1b in molar ratio 80:20 [4]. Thus, a solid solution of these two components as a single crystal structure was obtained during crystallization. Despite the fact that there are two components of IVM in crystals, this investigation will further focus on the main component of IVM, namely ivermectin-B1a. The molecular conformation of IVM in crystals has been compared with the conformation of isolated molecules modeled by DFT calculations [5]. It turned out the molecular conformation in the Free State is close to the one in the crystals. It is known that many molecules of macrocyclic compounds are characterized by the fact that the function of distribution of the electrostatic potential has considerable extrema [6]; this allows the molecules to form supramolecular adducts with ions and polar molecules. However, for the IVM molecule, the electrostatic potential obtained from the DFT calculation of the distribution of electron density does not contain significant extrema. This is also the case for other macrocyclic molecules [7]. For this reason, molecules of IVM can form inclusion compounds with polar molecules mostly due to the formation of hydrogen bonds.

In order to get an additional quantitative picture of the intermolecular interactions of the crystal structure of IVM, calculation of interaction energies was performed in CrystalExplorer 17 [8] by assessing the electrostatic, polarization, dispersion and exchangerepulsion terms that together form the total interaction energy. Calculations of the lattice energy indicate that interactions between IVM and solvents play a minor role; the main contribution to energy is made by the interactions between the molecules of IVM itself, which form a framework in the crystal structure by means of intermolecular hydrogen bonds. Notably lower contribution in the stabilization of this IVM crystal structure is provided by interaction between IVM and solvent molecules, and even here electrostatic interactions and dispersion interactions provide similar contribution, and only in the pair connected by a hydrogen bond the electrostatic components are the dominant ones. Thus, it has been hypothesized that IVM forms *Corresponding author: Chaturvedi K, Research Department, J-Star Research Inc, USA, E-mail: kaushalendra.chaturvedi@my.liu.edu Received: June 11, 2021; Accepted: June 25, 2021; Published: July 2, 2021 Copyright: © 2021 Chaturvedi K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Crystal Structures of New Ivermectin Pseudopolymorphs Shubin K, Bērziņš A, Belyakov S* Department of Applied Chemistry, Latvian Institute of Organic Synthesis, Riga, Latvia two types of the frameworks: monoclinic (space group I2) with a small volume of voids, and orthorhombic (space group P212121) where volume of voids is significantly larger than in the monoclinic case. In a solvent with relatively small molecules (ethanol), IVM forms monoclinic crystal structure. When crystallized from solvents with larger molecules, like gamma, valerolactone and methyl tertbutyl ether, IVM forms orthorhombic crystal structure with two independent molecules of IVM in the asymmetric unit. Interactions between IVM and molecules of solvents were evaluated using Hirshfeld surface analysis and two‐dimensional fingerprint plots of these Hirshfeld surfaces.

Thermal analysis of the new pseudopolymorphs of IVM was performed by differential scanning calorimetry and thermogravimetric analysis. The peculiarities of the crystal structures explain the thermal analysis data.

References

  1. Jans DA, Wagstaff KM (2020) Ivermectin as a broad‐spectrum host‐directed antiviral: The real deal? Cells. 9(9): 2100.
  2. Gupta SPS, Rana MK (2020) Ivermectin, famotidine, and doxycycline: A suggested combinatorial therapeutic for the treatment of COVID-19. Acs Pharm Transl Sci. 3(5): 1037–1038.
  3. Shubin K, Bērziņš A, Belyakov S (2021) Crystal structures of new ivermectin pseudopolymorphs. Crystals. 11(2): 172
  4. Campbell W, Fisher M, (1983) Stapley E, Albers‐Schonberg G, Jacob T. Ivermectin: A potent new antiparasitic agent. Science. 221(4613): 823-828.
  5. Bochevarov AD, Harder E, Hughes TF, Greenwood JR, Braden DA, et al. (2013) Jaguar: A high‐performance quantum chemistry software program with strengths in life and materials sciences. Int J Quantum Chem. 113: 2110–2142
  6. Marczenko KM, Mercier HPA (2018) Schrobilgen GJ. A stable crown ether complex with a noble‐gas compound. Angew Chem Int Ed. 57: 12448–12452
  7. Popov I, Chen TH, Belyakov S, Daugulis O, Wheeler SE, et al. (2015) Macrocycle embrace: Encapsulation of fluoroarenes by m‐phenylene ethynylene host. Chem A Eur J. 21: 2750–2754.
  8. Turner MJ, McKinnon JJ, Wolff SK, Grimwood DJ, Spackman PR, et al. (2017) Crystal explorer17; The University of Western Australia: Perth, WA, Australia.
Top